Skip to content
healthcare.dev

TREGZI

NDC 85866-223, allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq, kit, from Orca Biosystems Inc..

Product NDC
85866-223
Status
Listed
Labeler
Orca Biosystems Inc.
Dosage form
KIT
Route
—
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125868
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85866-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
85866-223-04858660223041 KIT in 1 CARTON (85866-223-04) * 100 mL in 1 BAG (85866-124-01) * 1 BAG in 1 CARTRIDGE (85866-126-02) / 15 mL in 1 BAG (85866-126-01) * 1 BAG in 1 CARTON (85866-127-02) / 30 mL in 1 BAG (85866-127-01) * 100 mL in 1 BAG (85866-125-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85866-223 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85866-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85866-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.